Design , synthesis of symmetric molecules as potential anti-HCV agents / (Record no. 66916)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01533cam a2200289 a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | EG-GiCUC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250223032026.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 180801s2017 ua dh f m 000 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EG-GiCUC |
| Language of cataloging | eng |
| Transcribing agency | EG-GiCUC |
| 041 0# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | Gift |
| 097 ## - Thesis Degree | |
| Thesis Level | M.Sc |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| Classification number | Cai01.34.M.Sc.2017.Al.D |
| 100 0# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Alaa Rizk Sanad Ibrahim Leila |
| 245 10 - TITLE STATEMENT | |
| Title | Design , synthesis of symmetric molecules as potential anti-HCV agents / |
| Statement of responsibility, etc. | Alaa Rizk Sanad Ibrahim Leila ; Supervised Ashraf H. Abadi , Mohammad Abdelhalim |
| 246 15 - VARYING FORM OF TITLE | |
| Title proper/short title | تصميم وتحضير الجزيئات المتماثلة المضادة لفيروس سي |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Cairo : |
| Name of publisher, distributor, etc. | Alaa Rizk Sanad Ibrahim Leila , |
| Date of publication, distribution, etc. | 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 101 Leaves : |
| Other physical details | charts , facsimiles ; |
| Dimensions | 30cm |
| 502 ## - DISSERTATION NOTE | |
| Dissertation note | Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Chemistry |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Until recently, the standard therapy for HCV treatment has been a combination of interferon Ü (IFNÜ) and ribavirin (RBV) which has severe side effects and contraindications. Cure rates reported for this combination therapy were about 50%¹{u⁰⁶⁶B}² therefore, direct-acting antivirals (DAAs) were developed to target viral proteins that are crucial for the HCV lifecycle |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ashraf H. Abadi , |
| Relator term | |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mohammad Abdelhalim , |
| Relator term | |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a> |
| 905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) | |
| Cataloger | Nazla |
| Reviser | Revisor |
| 905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) | |
| Cataloger | Shimaa |
| Reviser | Cataloger |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Thesis |
| Source of classification or shelving scheme | Not for loan | Home library | Current library | Date acquired | Full call number | Barcode | Date last seen | Koha item type |
|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | المكتبة المركزبة الجديدة - جامعة القاهرة | قاعة الثقاقات الاجنبية - الدور الثالث | 11.02.2024 | Cai01.34.M.Sc.2017.Al.D | 01010110075381000 | 05.07.2024 | Thesis |